Jeevandeep Mishra: Thrombotic Complications and Risk in COVID-19
Jeevandeep Mishra, Assistant Professor at Indore Institute of Pharmacy, Pithampur Road, Opp. IIM, Rau, Indore, shared a post on LinkedIn about a recent article he co-authored with Nimita Manocha, adding:
”I am proud to share a significant milestone in my academic journey-my book chapter titled ‘Thrombotic Events and Comprehensive Risk of SARS-CoV-2: An Overview’ has been published with Bentham Science.
This work provides a detailed overview of thrombotic complications associated with COVID-19, highlighting the underlying pathophysiological mechanisms, including hyperinflammatory responses, platelet activation, and the coagulation cascade.
It also explores the increased risk of conditions such as venous thromboembolism (VTE), pulmonary embolism (PE), deep vein thrombosis (DVT), and arterial thrombosis in affected patients.
Being part of this research has been an enriching experience, allowing me to deepen my understanding of the clinical and molecular aspects of COVID-19 and its complications.
This publication reinforces my commitment to advancing knowledge in pharmacology and healthcare research. I look forward to contributing further to impactful scientific work that addresses real-world health challenges.
I would like to extend my heartfelt gratitude to Dr. Nimita Grover Manocha ma’am (Principal, IIP) for her constant support, guidance, and encouragement throughout this journey. ”
Title: Thrombotic Events and Comprehensive Risk of SARS-CoV-2: An Overview
Authors: Nimita Manocha, Jeevandeep Mishra
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
-
Jun 3, 2026, 16:07Suraj Wilson: Back From ASCO 2026 With A Renewed Commitment To Cancer Research
-
Jun 3, 2026, 16:06Kerin A. Da Cruz: MSTU Team Is Creating The Future of Stroke Care In the Northeast Florida
-
Jun 3, 2026, 16:06Andrew Lee: Examining Rare Clotting Disorders After Adenovirus-Based COVID-19 Vaccination